246 EUR-1008 (a new pancraetic enzyme product, PEP) was shown to be safe and effective in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI)

✍ Scribed by J.E. Heubi; S.R. Boas; K. Blake; S.Z. Nasr; M.S. Woo; G.R. Graff; K.A. Hardy; R. Amaro-Galvez; M. Latino; C. Lee

• Book ID: 118641294
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 47 KB
• Volume: 6
• Category: Article
• ISSN: 1569-1993
• DOI: 10.1016/s1569-1993(07)60229-x